Symbols / ADTX Stock $0.59 -25.73% Aditxt, Inc.
ADTX (Stock) Chart
About
Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women's health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 305.54K |
| Enterprise Value | -1.13M | Income | -43.10M | Sales | 3.19K |
| Book/sh | -151.87 | Cash/sh | 3.54 | Dividend Yield | — |
| Payout | 0.00% | Employees | — | IPO | — |
| P/E | — | Forward P/E | -0.05 | PEG | — |
| P/S | 95.63 | P/B | -0.00 | P/C | — |
| EV/EBITDA | 0.06 | EV/Sales | -353.54 | Quick Ratio | 0.26 |
| Current Ratio | 0.31 | Debt/Eq | 76.04 | LT Debt/Eq | — |
| EPS (ttm) | -9230.64 | EPS next Y | -11.29 | EPS Growth | — |
| Revenue Growth | -86.60% | Earnings | 2023-11-14 17:00 | ROA | -50.27% |
| ROE | -6.99% | ROIC | — | Gross Margin | 8.39% |
| Oper. Margin | -10987.26% | Profit Margin | 0.00% | Shs Outstand | 517.86K |
| Shs Float | 824.84K | Short Float | 8.54% | Short Ratio | 0.45 |
| Short Interest | — | 52W High | 3959.52 | 52W Low | 0.53 |
| Beta | — | Avg Volume | 247.49K | Volume | 17.08M |
| Target Price | — | Recom | None | Prev Close | $0.79 |
| Price | $0.59 | Change | -25.73% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.60
Latest analyst target
3. DCF / Fair value
$-645.87
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.60
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2023-09-06 | main | HC Wainwright & Co. | Buy → Buy | $61 |
- ADTX | Aditxt, Inc. Common Stock Executive Compensation - Quiver Quantitative Sat, 04 Apr 2026 19
- 12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga Mon, 06 Apr 2026 21
- ADTX Surges 12.97% — But No Clear Catalyst Emerges - Bitget Mon, 06 Apr 2026 12
- Curious about the stocks that are showing activity after the closing bell on Monday? - ChartMill Mon, 06 Apr 2026 21
- Aditxt (NASDAQ: ADTX) back in line with Nasdaq equity listing rules - Stock Titan hu, 02 Apr 2026 13
- Aditxt Expands At-The-Market Equity Offering Capacity - The Globe and Mail ue, 31 Mar 2026 13
- $ADTX stock is down 35% today. Here's what we see in our data. - Quiver Quantitative Fri, 13 Mar 2026 07
- 12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga Mon, 06 Apr 2026 12
- Aditxt (NASDAQ: ADTX) seeks reverse stock split and say-on-pay nod - Stock Titan Fri, 03 Apr 2026 20
- 12 Health Care Stocks Moving In Monday's Intraday Session - ABVC BioPharma (NASDAQ:ABVC), Aditxt (NASDAQ - Benzinga Mon, 06 Apr 2026 17
- Aditxt cancer move: Ignite Proteomics to guide therapy for 600,000 - Stock Titan Fri, 13 Mar 2026 07
- ADTX Plummets 22.8% in Intraday Trading – What’s Fueling the Sudden Freefall? - Bitget Mon, 06 Apr 2026 14
- $ADTX stock is up 16% today. Here's what we see in our data. - Quiver Quantitative Fri, 16 Jan 2026 08
- ADTX Bounces Near Key Support — But Downtrend Intact - Bitget Sun, 05 Apr 2026 20
- Eight Aditxt shares become one as 1-for-8 Nasdaq reverse split starts March 9 - Stock Titan hu, 05 Mar 2026 08
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
-97.62%
|
0.13
-79.23%
|
0.65
-30.90%
|
0.93
|
| Operating Revenue |
|
0.00
-97.62%
|
0.13
-79.23%
|
0.65
-30.90%
|
0.93
|
| Cost Of Revenue |
|
0.00
-99.53%
|
0.63
-17.09%
|
0.76
-1.30%
|
0.77
|
| Reconciled Cost Of Revenue |
|
0.00
-99.53%
|
0.63
-17.09%
|
0.76
-1.30%
|
0.77
|
| Gross Profit |
|
0.00
+100.05%
|
-0.49
-341.96%
|
-0.11
-166.89%
|
0.17
|
| Operating Expense |
|
19.57
-28.50%
|
27.37
+5.47%
|
25.95
+3.38%
|
25.10
|
| Research And Development |
|
3.19
-70.66%
|
10.89
+53.88%
|
7.07
-2.67%
|
7.27
|
| Selling General And Administration |
|
16.38
-0.65%
|
16.48
-12.67%
|
18.88
+5.84%
|
17.84
|
| Selling And Marketing Expense |
|
0.40
+103.17%
|
0.20
-26.52%
|
0.27
-85.44%
|
1.85
|
| General And Administrative Expense |
|
15.97
-1.91%
|
16.29
-12.47%
|
18.61
+16.40%
|
15.99
|
| Other Gand A |
|
15.97
-1.91%
|
16.29
-12.47%
|
18.61
+16.40%
|
15.99
|
| Total Expenses |
|
19.57
-30.09%
|
28.00
+4.83%
|
26.71
+3.24%
|
25.87
|
| Operating Income |
|
-19.57
+29.76%
|
-27.86
-6.91%
|
-26.06
-4.52%
|
-24.94
|
| Total Operating Income As Reported |
|
-19.57
+29.76%
|
-27.86
-6.91%
|
-26.06
-2.29%
|
-25.48
|
| EBITDA |
|
-40.13
-48.40%
|
-27.04
-6.21%
|
-25.46
-2.54%
|
-24.83
|
| Normalized EBITDA |
|
-19.10
+30.44%
|
-27.45
-7.84%
|
-25.46
-4.83%
|
-24.28
|
| Reconciled Depreciation |
|
0.27
-55.84%
|
0.62
+13.76%
|
0.54
+1.23%
|
0.54
|
| EBIT |
|
-40.40
-46.08%
|
-27.66
-6.37%
|
-26.00
-2.51%
|
-25.36
|
| Total Unusual Items |
|
-21.03
-5173.24%
|
0.41
|
0.00
+100.00%
|
-0.54
|
| Total Unusual Items Excluding Goodwill |
|
-21.03
-5173.24%
|
0.41
|
0.00
+100.00%
|
-0.54
|
| Special Income Charges |
|
-23.85
|
0.00
|
0.00
+100.00%
|
-0.54
|
| Other Special Charges |
|
—
|
—
|
—
|
—
|
| Impairment Of Capital Assets |
|
0.41
|
0.00
|
—
|
—
|
| Restructuring And Mergern Acquisition |
|
-0.33
|
0.00
|
—
|
—
|
| Write Off |
|
23.77
|
0.00
|
0.00
-100.00%
|
0.54
|
| Net Income |
|
-41.71
-21.10%
|
-34.45
-6.38%
|
-32.38
-17.11%
|
-27.65
|
| Pretax Income |
|
-42.79
-22.18%
|
-35.02
-8.12%
|
-32.39
-17.14%
|
-27.65
|
| Net Non Operating Interest Income Expense |
|
-2.19
+70.29%
|
-7.36
-15.40%
|
-6.38
-186.25%
|
-2.23
|
| Interest Expense Non Operating |
|
2.39
-67.57%
|
7.36
+15.24%
|
6.39
+179.51%
|
2.29
|
| Net Interest Income |
|
-2.19
+70.29%
|
-7.36
-15.40%
|
-6.38
-186.25%
|
-2.23
|
| Interest Expense |
|
2.39
-67.57%
|
7.36
+15.24%
|
6.39
+179.51%
|
2.29
|
| Interest Income Non Operating |
|
0.20
+13667.47%
|
0.00
-85.70%
|
0.01
-82.27%
|
0.06
|
| Interest Income |
|
0.20
+13667.47%
|
0.00
-85.70%
|
0.01
-82.27%
|
0.06
|
| Other Income Expense |
|
-21.03
-10316.46%
|
0.21
+298.03%
|
0.05
+110.66%
|
-0.48
|
| Other Non Operating Income Expenses |
|
—
|
-0.21
-503.52%
|
0.05
-12.29%
|
0.06
|
| Gain On Sale Of Security |
|
2.82
+580.70%
|
0.41
+701.56%
|
0.05
|
—
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-42.79
-22.18%
|
-35.02
-8.12%
|
-32.39
-17.14%
|
-27.65
|
| Net Income From Continuing Operation Net Minority Interest |
|
-41.71
-21.10%
|
-34.45
-6.38%
|
-32.38
-17.11%
|
-27.65
|
| Net Income From Continuing And Discontinued Operation |
|
-41.71
-21.10%
|
-34.45
-6.38%
|
-32.38
-17.11%
|
-27.65
|
| Net Income Continuous Operations |
|
-42.79
-22.18%
|
-35.02
-8.12%
|
-32.39
-17.14%
|
-27.65
|
| Minority Interests |
|
1.07
+87.05%
|
0.57
+5869.73%
|
0.01
|
0.00
|
| Normalized Income |
|
-20.69
+40.66%
|
-34.86
-7.66%
|
-32.38
-19.46%
|
-27.11
|
| Net Income Common Stockholders |
|
-43.10
-6.81%
|
-40.35
-23.40%
|
-32.70
-18.11%
|
-27.69
|
| Otherunder Preferred Stock Dividend |
|
1.39
-76.52%
|
5.91
+1746.69%
|
0.32
+749.21%
|
0.04
|
| Diluted EPS |
|
—
|
-282,192.29
-13.05%
|
-249,623.74
+90.98%
|
-2,768,755.30
|
| Basic EPS |
|
—
|
-282,192.29
-13.05%
|
-249,623.74
+90.98%
|
-2,768,755.30
|
| Basic Average Shares |
|
—
|
0.00
+9.16%
|
0.00
+1210.00%
|
0.00
|
| Diluted Average Shares |
|
—
|
0.00
+9.16%
|
0.00
+1210.00%
|
0.00
|
| Diluted NI Availto Com Stockholders |
|
-43.10
-6.81%
|
-40.35
-23.40%
|
-32.70
-18.11%
|
-27.69
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
32.14
-27.89%
|
44.58
+315.25%
|
10.74
|
—
|
| Current Assets |
|
2.00
-71.07%
|
6.91
+45.73%
|
4.74
|
—
|
| Cash Cash Equivalents And Short Term Investments |
|
0.83
+757.89%
|
0.10
-96.49%
|
2.77
|
—
|
| Cash And Cash Equivalents |
|
0.83
+757.89%
|
0.10
-96.49%
|
2.77
|
—
|
| Cash Financial |
|
0.83
+757.89%
|
0.10
-96.49%
|
2.77
|
—
|
| Receivables |
|
1.15
-80.31%
|
5.85
+1008.60%
|
0.53
|
—
|
| Accounts Receivable |
|
0.04
-89.36%
|
0.41
-22.66%
|
0.53
|
—
|
| Gross Accounts Receivable |
|
0.05
-88.38%
|
0.41
-25.30%
|
0.55
|
—
|
| Allowance For Doubtful Accounts Receivable |
|
-0.00
|
0.00
+100.00%
|
-0.02
|
—
|
| Other Receivables |
|
1.11
-79.64%
|
5.44
|
—
|
—
|
| Inventory |
|
0.01
-98.49%
|
0.75
-21.53%
|
0.95
|
—
|
| Raw Materials |
|
—
|
—
|
0.95
+92.06%
|
0.49
|
| Prepaid Assets |
|
0.00
-98.45%
|
0.22
-56.25%
|
0.50
|
—
|
| Total Non Current Assets |
|
30.14
-19.97%
|
37.67
+528.63%
|
5.99
|
—
|
| Net PPE |
|
2.77
-32.33%
|
4.10
-25.20%
|
5.48
|
—
|
| Gross PPE |
|
4.62
-13.71%
|
5.35
-15.02%
|
6.30
|
—
|
| Accumulated Depreciation |
|
-1.84
-47.30%
|
-1.25
-53.31%
|
-0.82
|
—
|
| Properties |
|
0.00
|
0.00
|
0.00
|
—
|
| Buildings And Improvements |
|
—
|
2.20
-30.38%
|
3.16
|
—
|
| Machinery Furniture Equipment |
|
0.44
+0.00%
|
0.44
+0.47%
|
0.43
|
—
|
| Other Properties |
|
4.06
-15.30%
|
4.79
+85.72%
|
2.58
|
—
|
| Leases |
|
0.12
+0.00%
|
0.12
+0.00%
|
0.12
|
—
|
| Goodwill And Other Intangible Assets |
|
0.01
-35.29%
|
0.01
-91.17%
|
0.11
|
—
|
| Other Intangible Assets |
|
0.01
-35.29%
|
0.01
-91.17%
|
0.11
|
—
|
| Investments And Advances |
|
27.28
+22.44%
|
22.28
|
0.00
|
—
|
| Long Term Equity Investment |
|
27.28
+22.44%
|
22.28
|
0.00
|
—
|
| Non Current Deferred Assets |
|
—
|
0.00
-100.00%
|
0.05
|
0.00
|
| Non Current Prepaid Assets |
|
0.09
-99.22%
|
11.28
+3074.24%
|
0.36
|
—
|
| Other Non Current Assets |
|
—
|
—
|
—
|
0.29
|
| Total Liabilities Net Minority Interest |
|
31.05
+8.84%
|
28.53
+416.04%
|
5.53
|
—
|
| Current Liabilities |
|
23.41
-9.59%
|
25.89
+610.53%
|
3.64
|
—
|
| Payables And Accrued Expenses |
|
15.46
+80.74%
|
8.55
+336.81%
|
1.96
|
—
|
| Payables |
|
12.44
+65.38%
|
7.52
|
—
|
—
|
| Accounts Payable |
|
10.19
+35.47%
|
7.52
|
—
|
—
|
| Other Payable |
|
2.25
|
—
|
—
|
—
|
| Current Accrued Expenses |
|
3.02
+192.82%
|
1.03
|
—
|
—
|
| Current Debt And Capital Lease Obligation |
|
6.48
-62.25%
|
17.18
+1047.65%
|
1.50
|
—
|
| Current Debt |
|
5.80
-64.14%
|
16.18
+3845.60%
|
0.41
|
—
|
| Other Current Borrowings |
|
0.15
+0.00%
|
0.15
-63.94%
|
0.41
-41.47%
|
0.70
|
| Current Capital Lease Obligation |
|
0.68
-31.66%
|
1.00
-7.98%
|
1.09
|
—
|
| Current Deferred Liabilities |
|
0.11
-33.12%
|
0.16
-15.89%
|
0.19
|
—
|
| Other Current Liabilities |
|
1.35
|
—
|
—
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
7.65
+189.43%
|
2.64
+40.13%
|
1.89
|
—
|
| Long Term Debt And Capital Lease Obligation |
|
0.44
-58.11%
|
1.04
-44.74%
|
1.89
|
—
|
| Long Term Debt |
|
—
|
—
|
—
|
0.11
|
| Long Term Capital Lease Obligation |
|
0.44
-58.11%
|
1.04
-44.74%
|
1.89
|
—
|
| Other Non Current Liabilities |
|
—
|
1.60
|
—
|
—
|
| Preferred Securities Outside Stock Equity |
|
7.20
|
—
|
—
|
—
|
| Stockholders Equity |
|
1.67
-89.57%
|
16.06
+208.40%
|
5.21
|
—
|
| Common Stock Equity |
|
1.67
-89.57%
|
16.06
+208.40%
|
5.21
|
—
|
| Capital Stock |
|
0.00
-19.44%
|
0.00
-66.67%
|
0.00
|
—
|
| Common Stock |
|
0.00
-90.91%
|
0.00
-89.81%
|
0.00
|
—
|
| Preferred Stock |
|
0.00
+12.00%
|
0.00
|
0.00
|
—
|
| Share Issued |
|
0.00
+9.16%
|
0.00
+1210.00%
|
0.00
|
—
|
| Ordinary Shares Number |
|
0.00
|
0.00
-100.00%
|
0.00
|
—
|
| Treasury Shares Number |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Additional Paid In Capital |
|
169.97
+18.04%
|
144.00
+43.36%
|
100.45
|
—
|
| Retained Earnings |
|
-168.09
-31.59%
|
-127.74
-34.41%
|
-95.04
|
—
|
| Gains Losses Not Affecting Retained Earnings |
|
0.00
|
—
|
—
|
—
|
| Treasury Stock |
|
0.20
+0.00%
|
0.20
+0.00%
|
0.20
|
—
|
| Minority Interest |
|
-0.58
-5969.73%
|
-0.01
|
0.00
|
—
|
| Other Equity Adjustments |
|
—
|
—
|
—
|
—
|
| Total Equity Gross Minority Interest |
|
1.09
-93.20%
|
16.05
+208.22%
|
5.21
|
—
|
| Total Capitalization |
|
1.67
-89.57%
|
16.06
+208.40%
|
5.21
|
—
|
| Working Capital |
|
-21.41
-12.81%
|
-18.98
-1825.42%
|
1.10
|
—
|
| Invested Capital |
|
7.48
-76.81%
|
32.23
+473.91%
|
5.62
|
—
|
| Total Debt |
|
6.92
-62.01%
|
18.22
+438.70%
|
3.38
|
—
|
| Net Debt |
|
4.97
-69.11%
|
16.08
|
—
|
—
|
| Capital Lease Obligations |
|
1.12
-45.16%
|
2.04
-31.30%
|
2.97
|
—
|
| Net Tangible Assets |
|
1.67
-89.60%
|
16.05
+214.69%
|
5.10
|
—
|
| Tangible Book Value |
|
1.67
-89.60%
|
16.05
+214.69%
|
5.10
|
—
|
| Current Notes Payable |
|
5.65
-64.73%
|
16.03
|
0.00
|
—
|
| Derivative Product Liabilities |
|
0.01
|
0.00
|
—
|
—
|
| Interest Payable |
|
1.89
+387.38%
|
0.39
|
—
|
—
|
| Investmentsin Subsidiariesat Cost |
|
27.28
+22.44%
|
22.28
|
0.00
|
—
|
| Non Current Note Receivables |
|
0.00
|
—
|
—
|
—
|
| Notes Receivable |
|
—
|
—
|
0.00
-100.00%
|
0.50
|
| Preferred Stock Equity |
|
0.00
+12.00%
|
0.00
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-25.69
-53.25%
|
-16.76
+12.71%
|
-19.20
+14.24%
|
-22.39
|
| Cash Flow From Continuing Operating Activities |
|
-25.69
-53.25%
|
-16.76
+12.71%
|
-19.20
+14.24%
|
-22.39
|
| Net Income From Continuing Operations |
|
-42.79
-22.18%
|
-35.02
-8.12%
|
-32.39
-17.14%
|
-27.65
|
| Depreciation Amortization Depletion |
|
0.27
-55.84%
|
0.62
+13.76%
|
0.54
+1.23%
|
0.54
|
| Depreciation |
|
0.27
-56.14%
|
0.61
+41.12%
|
0.44
+1.41%
|
0.43
|
| Amortization Cash Flow |
|
0.00
+0.00%
|
0.00
-96.90%
|
0.11
+0.52%
|
0.11
|
| Depreciation And Amortization |
|
0.27
-55.84%
|
0.62
+13.76%
|
0.54
+1.23%
|
0.54
|
| Amortization Of Intangibles |
|
0.00
+0.00%
|
0.00
-96.90%
|
0.11
+0.52%
|
0.11
|
| Other Non Cash Items |
|
1.16
-72.51%
|
4.21
+96.56%
|
2.14
+39.79%
|
1.53
|
| Stock Based Compensation |
|
0.48
-92.84%
|
6.75
+381.14%
|
1.40
-55.23%
|
3.13
|
| Asset Impairment Charge |
|
24.18
|
0.00
|
0.00
-100.00%
|
0.54
|
| Operating Gains Losses |
|
-2.82
-585.66%
|
-0.41
|
—
|
0.01
|
| Gain Loss On Investment Securities |
|
-2.82
-580.70%
|
-0.41
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
0.00
-100.00%
|
0.00
|
0.00
-100.00%
|
0.01
|
| Change In Working Capital |
|
-6.17
-187.00%
|
7.09
-22.04%
|
9.10
+1944.03%
|
-0.49
|
| Change In Receivables |
|
0.04
-88.10%
|
0.36
+205.00%
|
0.12
+127.31%
|
-0.44
|
| Changes In Account Receivables |
|
0.04
-88.10%
|
0.36
+205.00%
|
0.12
+127.31%
|
-0.44
|
| Change In Inventory |
|
0.01
-99.25%
|
0.73
+258.89%
|
0.20
+144.93%
|
-0.46
|
| Change In Prepaid Assets |
|
-0.59
-352.59%
|
0.23
-55.96%
|
0.53
+4201.80%
|
-0.01
|
| Change In Payables And Accrued Expense |
|
-5.63
-210.56%
|
5.10
-23.34%
|
6.65
+1509.47%
|
0.41
|
| Change In Other Current Liabilities |
|
0.00
-100.00%
|
0.67
-58.31%
|
1.60
|
0.00
|
| Investing Cash Flow |
|
-2.44
+51.23%
|
-5.00
-34605.35%
|
-0.01
+94.04%
|
-0.24
|
| Cash Flow From Continuing Investing Activities |
|
-2.44
+51.23%
|
-5.00
-34605.35%
|
-0.01
+94.04%
|
-0.24
|
| Net PPE Purchase And Sale |
|
-0.01
|
0.00
+100.00%
|
-0.01
+96.08%
|
-0.37
|
| Purchase Of PPE |
|
-0.01
|
0.00
+100.00%
|
-0.01
+96.08%
|
-0.37
|
| Capital Expenditure |
|
-0.01
|
—
|
-0.01
+96.08%
|
-0.37
|
| Net Investment Purchase And Sale |
|
0.00
+100.00%
|
-5.00
|
0.00
|
—
|
| Purchase Of Investment |
|
0.00
+100.00%
|
-5.00
|
0.00
|
—
|
| Net Other Investing Changes |
|
-2.42
|
—
|
—
|
0.13
|
| Financing Cash Flow |
|
30.49
+35.53%
|
22.50
+35.97%
|
16.55
-5.61%
|
17.53
|
| Cash Flow From Continuing Financing Activities |
|
30.49
+35.53%
|
22.50
+35.97%
|
16.55
-5.61%
|
17.53
|
| Net Issuance Payments Of Debt |
|
-5.54
-295.90%
|
-1.40
-124.31%
|
5.75
+1496.70%
|
-0.41
|
| Issuance Of Debt |
|
1.87
-59.51%
|
4.62
-51.88%
|
9.59
+233.66%
|
2.88
|
| Repayment Of Debt |
|
-7.41
-23.14%
|
-6.01
-56.64%
|
-3.84
-16.83%
|
-3.29
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
2.88
|
| Long Term Debt Payments |
|
—
|
—
|
—
|
-3.69
|
| Net Long Term Debt Issuance |
|
—
|
—
|
—
|
-0.81
|
| Short Term Debt Issuance |
|
1.87
-59.51%
|
4.62
-51.88%
|
9.59
+233.66%
|
2.88
|
| Short Term Debt Payments |
|
-7.41
-23.14%
|
-6.01
-56.64%
|
-3.84
-16.83%
|
-3.29
|
| Net Short Term Debt Issuance |
|
-5.54
-295.90%
|
-1.40
-124.31%
|
5.75
+1496.70%
|
-0.41
|
| Net Common Stock Issuance |
|
44.13
+108.48%
|
21.17
+91.47%
|
11.05
-35.85%
|
17.23
|
| Repurchase Of Capital Stock |
|
-9.21
-222.82%
|
-2.85
-285087.10%
|
-0.00
+95.00%
|
-0.02
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
1.25
|
0.00
-100.00%
|
1.11
|
| Net Other Financing Charges |
|
1.11
-74.43%
|
4.34
+1760.24%
|
-0.26
+34.79%
|
-0.40
|
| Changes In Cash |
|
2.37
+221.44%
|
0.74
+127.55%
|
-2.67
+47.65%
|
-5.10
|
| Beginning Cash Position |
|
0.83
+757.89%
|
0.10
-96.49%
|
2.77
-64.83%
|
7.87
|
| End Cash Position |
|
3.20
+283.97%
|
0.83
+757.89%
|
0.10
-96.49%
|
2.77
|
| Free Cash Flow |
|
-25.70
-53.33%
|
-16.76
+12.78%
|
-19.22
+15.56%
|
-22.76
|
| Interest Paid Supplemental Data |
|
2.47
+99.54%
|
1.24
-59.76%
|
3.07
+307.76%
|
0.75
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock Issuance |
|
44.13
+108.48%
|
21.17
+91.47%
|
11.05
-35.85%
|
17.23
|
| Issuance Of Capital Stock |
|
44.13
+108.48%
|
21.17
+91.45%
|
11.06
-35.92%
|
17.25
|
| Net Preferred Stock Issuance |
|
-9.21
-222.82%
|
-2.85
|
0.00
|
0.00
|
| Preferred Stock Issuance |
|
—
|
0.00
-100.00%
|
0.00
-95.00%
|
0.02
|
| Preferred Stock Payments |
|
-9.21
-222.82%
|
-2.85
-285087.10%
|
-0.00
+95.00%
|
-0.02
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-02 View
- 10-K2026-03-31 View
- 8-K2026-03-30 View
- 8-K2026-03-13 View
- 8-K2026-03-05 View
- 8-K2026-02-13 View
- 8-K2026-01-30 View
- 8-K2026-01-28 View
- 42025-12-19 View
- 8-K2025-12-05 View
- 42025-11-26 View
- 8-K2025-11-18 View
- 10-Q2025-11-18 View
- 8-K2025-10-31 View
- 8-K2025-10-20 View
- 8-K2025-10-03 View
- 8-K2025-09-24 View
- 8-K2025-09-16 View
- 8-K2025-08-27 View
- 10-Q2025-08-14 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|